The June 2023 replay of past episodes showcases a selection of interviews regarding the biomarker discovery in Parkinson disease. This episode begins with an overview of the latest in Parkinson’s research, including biomarker development with Dr. Bas Bloom. The episode continues with an interview with Dr. Lucilla Parnetti about the clinical application of α-synuclein seed amplification, leading into an interview with Prof. Andrew Siderowf about seed amplification in PD in the PPMI cohort. The June Neurology Recall concludes with an interview with Dr. Christopher Gibbons on skin α-synuclein in MSA and PD.
Related Podcast Links:
Biomarker and Treatment Development in Movement Disorders: https://directory.libsyn.com/episode/index/id/26775207)
Alpha-synuclein Amplification for Disease Diagnosis: https://directory.libsyn.com/episode/index/id/23923047)
α-Synuclein Seed Amplification in a Large Parkinson Cohort: https://directory.libsyn.com/episode/index/id/26961315)
Skin α-Synuclein In MSA and PD: h)ttps://directory.libsyn.com/episode/index/id/26499948)
Related Article Links:
Research in Movement Disorders in 2022: A New Era of Biomarker and Treatment Development: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00494-X/fulltex)
Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward: https://n.neurology.org/content/99/5/195)
Assessment of Heterogeneity Among Participants in the Parkinson's Progression Markers Initiative Cohort Using _-Synuclein Seed Amplification: A Cross-Sectional Study: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00109-6/fulltext)
Cutaneous _-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease: https://n.neurology.org/content/100/15/e1529)
Disclosures can be found at Neurology.org)
